Novel players in female fertility: The long pentraxin PTX3 and the chemokine decoy receptor D6

Advances in Neuroimmune Biology

Volumn 2, Issue 1-2, 2011, Pages 41-50

  Garlanda, Cecilia ^a   Maina, Virginia ^a   De La Torre, Yeny Martinez ^a   Nebuloni, Manuela ^b   Locati, Massimo ^a,c  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

chemokines; decoy receptor; female fertility; inflammation; Pentraxins

Indexed keywords

DECOY RECEPTOR 6; FIBROBLAST GROWTH FACTOR 2; PENTRAXIN 3; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; DECIDUALIZATION; FEMALE FERTILITY; GENETIC VARIABILITY; HUMAN; INFLAMMATION; INNATE IMMUNITY; MOTHER FETUS RELATIONSHIP; NIDATION; NONHUMAN; PHAGOCYTOSIS; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TROPHOBLAST; UPREGULATION;

EID: 84860124716     PISSN: 1878948X     EISSN: 18789498     Source Type: Journal    
DOI: 10.3233/NIB-2011-024     Document Type: Article

References (93)

1. Salamonsen LA, Dimitriadis E, Jones RL, et al. Complex regulation of decidualization: A role for cytokines and proteases-a review. Placenta. 2003; 24(Suppl A): S76-S85.
2. Genbacev OD, Prakobphol A, Foulk RA, et al. Trophoblast l-selectin-mediated adhesion at the maternal-fetal interface. Science. 2003; 299: 405-408.
3. Red-Horse K, Zhou Y, Genbacev O, et al. Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface. J Clin Invest. 2004; 114: 744-754.
4. Leonard S, Murrant C,Tayade C, et al. Mechanisms regulating immune cell contributions to spiral artery modification - facts and hypotheses - a review. Placenta. 2006; 27(Suppl A): S40-S46.
5. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005; 308: 1592-1594.
6. Reese J, Das SK, Paria BC, et al. Global gene expression analysis to identify molecular markers of uterine receptivity and embryo implantation. J Biol Chem. 2001; 276: 44137-44145.
7. Popovici RM, Betzler NK, Krause MS, et al. Gene expression profiling of human endometrial-trophoblast interaction in a coculture model. Endocrinology. 2006; 147: 5662-5675.
8. Hess AP, Hamilton AE, Talbi S, et al. Decidual stromal cell response to paracrine signals from the trophoblast: Amplification of immune and angiogenic modulators. Biol Reprod. 2007; 76: 102-117.
9. Dimitriadis E, White CA, Jones RL, et al. Cytokines, chemokines and growth factors in endometrium related to implantation. Hum Reprod Update. 2005; 11: 613-630.
10. Lindhard A, Bentin-Ley U, Ravn V, et al. Biochemical evaluation of endometrial function at the time of implantation. Fertil Steril. 2002; 78: 221-233.
11. Rossi M, Sharkey AM, Vigano P, et al. Identification of genes regulated by interleukin-1beta in human endometrial stromal cells. Reproduction. 2005; 130: 721-729.
12. Vigano P, Mangioni S, Pompei F, et al. Maternal-conceptus cross talk-a review. Placenta. 2003; 24(Suppl B): S56-S61.
13. Gonzalez RR, Devoto L, Campana A, et al. Effects of leptin, interleukin-1alpha, interleukin-6, and transforming growth factor-beta on markers of trophoblast invasive phenotype: Integrins and metalloproteinases. Endocrine. 2001; 15: 157-164.
14. Sanchez-Cuenca J, Martin JC, Pellicer A, et al. Cytokine pleiotropy and redundancy-gp130 cytokines in human implantation. Immunol Today. 1999; 20: 57-59.
15. Guzeloglu-Kayisli O, Basar M, Arici A. Basic aspects of implantation. Reprod Biomed Online. 2007; 15: 728-739.
16. Girardi G, Bulla R, Salmon JE, et al. The complement system in the pathophysiology of pregnancy. Mol Immunol. 2006; 43: 68-77.
17. Xu C, Mao D, Holers VM, et al. A critical role for murine complement regulator crry in fetomaternal tolerance. Science. 2000; 287: 498-501.
18. Agostinis C, Bulla R, Tripodo C, et al. An alternative role of C1q in cell migration and tissue remodeling: Contribution to trophoblast invasion and placental development. J Immunol. 2010; 185: 4420-4429.
19. Salamonsen LA, Zhang J, Brasted M. Leukocyte networks and human endometrial remodelling. J Reprod Immunol. 2002; 57: 95-108.
20. Hanna J, Goldman-Wohl D, Hamani Y, et al. Decidual NK cells regulate key developmental processes at the human fetalmaternal interface. Nat Med. 2006; 12: 1065-1074.
21. Sargent IL, Borzychowski AM, Redman CW. NK cells and human pregnancy-an inflammatory view. Trends Immunol. 2006; 27: 399-404.
22. Carlino C, Stabile H, Morrone S, et al. Recruitment of circulating NK cells through decidual tissues: A possible mechanism controlling NK cell accumulation in the uterus during early pregnancy. Blood. 2008; 111: 3108-3115.
23. Kitaya K, Yamaguchi T, Yasuo T, et al. Post-ovulatory rise of endometrial CD16(-) natural killer cells: In situ proliferation of residual cells or selective recruitment from circulating peripheral blood? J Reprod Immunol. 2007; 76: 45-53.
24. Bottazzi B, Doni A, Garlanda C, et al. An integrated view of humoral innate immunity: Pentraxins as a paradigm. Annu Rev Immunol. 2010; 28: 157-183.
25. Garlanda C, Bottazzi B, Bastone A, et al. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol. 2005; 23: 337-366.
26. Martinez de la Torre Y, Fabbri M, Jaillon S, et al. Evolution of the pentraxin family: The new entry PTX4. J Immunol. 2010; 184: 5055-5064.
27. Inforzato A, Peri G, Doni A, et al. Structure and function of the long pentraxin PTX3 glycosidic moiety: Fine-tuning of the interaction with C1q and complement activation. Biochemistry. 2006; 45: 11540-11551.
28. Inforzato A, RivieccioV, MorrealeAP, et al. Structural characterization of PTX3 disulfide bond network and its multimeric status in cumulus matrix organization. J Biol Chem. 2008; 283: 10147-10161.
29. Bottazzi B, Garlanda C, Cotena A, et al. The long pentraxin PTX3 as a prototypic humoral pattern recognition receptor: Interplay with cellular innate immunity. Immunological Reviews. 2009; 227: 9-18.
30. Norata GD, Marchesi P, Pirillo A, et al. Long pentraxin 3, a key component of innate immunity, is modulated by highdensity lipoproteins in endothelial cells. Arterioscler Thromb Vasc Biol. 2008; 28: 925-931.
31. Doni A, Peri G, Chieppa M, et al. Production of the soluble pattern recognition receptor PTX3 by myeloid, but not plasmacytoid, dendritic cells. Eur J Immunol. 2003; 33: 2886-2893.
32. Jaillon S, Peri G, Delneste Y, et al. The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps. J Exp Med. 2007; 204:793-804.
33. Varani S, Elvin JA, Yan C, et al. Knockout of pentraxin 3, a downstream target of growth differentiation factor-9, causes female subfertility. Mol Endocrinol. 2002; 16: 1154-1167.
34. Salustri A, Garlanda C, Hirsch E, et al. PTX3 plays a key role in the organization of the cumulus oophorus extracellular matrix and in in vivo fertilization. Development. 2004; 131: 1577-1586.
35. Salio M, Chimenti S, De Angelis N, et al. Cardioprotective function of the long pentraxin PTX3 in acute myocardial infarction. Circulation. 2008; 117: 1055-1064.
36. Han B, Mura M, Andrade CF, et al. TNFalpha-induced long pentraxin PTX3 expression in human lung epithelial cells via JNK. J Immunol. 2005; 175: 8303-8311.
37. Willeke F, Assad A, Findeisen P, et al. Overexpression of a member of the pentraxin family (PTX3) in human soft tissue liposarcoma. Eur J Cancer. 2006; 42: 2639-2646.
38. Doni A, Mantovani G, Porta C, et al. Cell-specific regulation of PTX3 by glucocorticoid hormones in hematopoietic and non-hematopoietic cells. J Biol Chem. 2008; 283: 29983-29992.
39. Garlanda C, Hirsch E, Bozza S, et al. Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature. 2002; 420: 182-186.
40. Diniz SN, Nomizo R, Cisalpino PS, et al. PTX3 function as an opsonin for the dectin-1-dependent internalization of zymosan by macrophages. J Leukoc Biol. 2004; 75: 649-656.
41. Jeannin P, Bottazzi B, Sironi M, et al. Complexity and complementarity of outer membrane proteinArecognition by cellular and humoral innate immunity receptors. Immunity. 2005; 22: 551-560.
42. Bozza S, Bistoni F, Gaziano R, et al. Pentraxin 3 rotects from MCMV infection and reactivation through TLR sensing pathways leading to IRF3 activation. Blood. 2006; 108: 3387-3396.
43. Reading PC, Bozza S, Gilbertson B, et al. Antiviral activity of the long chain pentraxin PTX3 against influenza viruses. J Immunol. 2008; 180: 3391-3398.
44. Cotena A, Maina V, Sironi M, et al. Complement dependent amplification of the innate response to a cognate microbial ligand by the long pentraxin PTX3. J Immunol. 2007; 179: 6311-6317.
45. Bottazzi B, Vouret-Craviari V, Bastone A, et al. Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component. J Biol Chem. 1997; 272: 32817-32823.
46. Nauta AJ, Bottazzi B, Mantovani A, et al. Biochemical and functional characterization of the interaction between pentraxin 3 and C1q. Eur J Immunol. 2003; 33: 465-473.
47. Jarva H, Jokiranta TS, Hellwage J, et al. Regulation of complement activation by C-reactive protein: Targeting the complement inhibitory activity of factor H by an interaction with short consensus repeat domains 7 and 8-11. J Immunol. 1999; 163: 3957-3962.
48. Deban L, Jarva H, Lehtinen MJ, et al. Binding of the long pentraxin PTX3 to Factor H: Interacting domains and function in the regulation of complement activation. J Immunology. 2008; 181: 8433-8440.
49. Ma YJ, Doni A, Hummelshoj T, et al. Synergy between ficolin-2 and pentraxin 3 boosts innate immune recognition and complement deposition. J Biol Chem. 2009; 284: 28263-28275.
50. Ma YJ, Doni A, Skjoedt MO, et al. Heterocomplexes of mannose-binding lectin and the pentraxins PTX3 or serum amyloid P component trigger cross-activation of the complement system. J Biol Chem. 2011; 286: 3405-3417.
51. Ng PM, Le Saux A, Lee CM, et al. C-reactive protein collaborates with plasma lectins to boost immune response against bacteria. Embo J. 2007; 26: 3431-3440.
52. Zhang J, Koh J, Lu J, et al. Local inflammation induces complement crosstalk which amplifies the antimicrobial response. PLoS Pathog. 2009; 5: e1000282.
53. Camozzi M, Rusnati M, Bugatti A, et al. Identification of an antiangiogenic FGF2-binding site in the N terminus of the soluble pattern recognition receptor PTX3. J Biol Chem. 2006; 281: 22605-22613.
54. Scarchilli L, Camaioni A, Bottazzi B, et al. PTX3 interacts with inter-alpha-trypsin inhibitor: Implications for hyaluronan organization and cumulus oophorus expansion. J Biol Chem. 2007; 282: 30161-30170.
55. Moalli F, Doni A, Deban L, et al. Role of complement and Fcgamma receptors in the protective activity of the long pentraxin PTX3 against Aspergillus fumigatus. Blood. 2010; 116: 5170-5180.
56. Lu J, Marnell LL, Marjon KD, et al. Structural recognition and functional activation of FcgammaR by innate pentraxins. Nature. 2008; 456: 989-992.
57. Dias AA, Goodman AR, Dos Santos JL, et al. TSG-14 transgenic mice have improved survival to endotoxemia and to CLP-induced sepsis. J Leukoc Biol. 2001; 69: 928-936.
58. Norata GD, Marchesi P, Pulakazhi Venu VK, et al. Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis. Circulation. 2009; 120: 699-708.
59. Deban L, Russo RC, Sironi M, et al. Regulation of leukocyte recruitment by the long pentraxin PTX3. Nat Immunol. 2010; 11: 328-334.
60. Zhang X, Jafari N, Barnes RB, et al. Studies of gene expression in human cumulus cells indicate pentraxin 3 as a possible marker for oocyte quality. Fertil Steril. 2005; 83(Suppl 1): 1169-1179.
61. Russell DL, Salustri A. Extracellular matrix of the cumulusoocyte complex. Semin Reprod Med. 2006; 24: 217-227.
62. Day AJ, de la Motte CA. Hyaluronan cross-linking: A protective mechanism in inflammation? Trends Immunol. 2005; 26: 637-643.
63. Maina V, Cotena A, Doni A, et al. Coregulation in human leukocytes of the long pentraxin PTX3 and TSG-6. J Leukoc Biol. 2009; 86: 123-132.
64. Paffoni A, Ragni G, Doni A, et al. Follicular fluid levels of the long pentraxin PTX3. J Soc Gynecol Investig. 2006; 13: 226-231.
65. Tranguch S, Chakrabarty A, Guo Y, et al. Maternal pentraxin 3 deficiency compromises implantation in mice. Biol Reprod. 2007; 77: 425-432.
66. Popovici RM, Krause MS, Jauckus J, et al. The long pentraxin PTX3 in human endometrium: Regulation by steroids and trophoblast products. Endocrinology. 2008; 149: 1136-1143.
67. Mantovani A, Garlanda C, Doni A, et al. Pentraxins in innate immunity: From C-reactive protein to the long pentraxin PTX3. J Clin Immunol. 2008; 28: 1-13.
68. Norata GD, Garlanda C, Catapano AL. The long pentraxin PTX3: A modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases. Trends Cardiovasc Med. 2010; 20: 35-40.
69. Azzurri A, Sow OY, Amedei A, et al. IFN-gamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection. Microbes Infect. 2005; 7: 1-8.
70. Mairuhu AT, Peri G, Setiati TE, et al. Elevated plasma levels of the long pentraxin, pentraxin 3, in severe dengue virus infections. J Med Virol. 2005; 76: 547-552.
71. Mauri T, Bellani G, Patroniti N, et al. Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality. Intensive Care Med. 2010; 36: 621-629.
72. Sprong T, Peri G, Neeleman C, et al. Pentraxin 3 and C-reactive protein in severe meningococcal disease. Shock. 2009; 31: 28-32.
73. Cetin I, CozziV, Pasqualini F, et al. Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restriction. Am J Obstet Gynecol. 2006; 194: 1347-1353.
74. Rovere-Querini P, Antonacci S, Dell'Antonio G, et al. Plasma and tissue expression of the long pentraxin 3 during normal pregnancy and preeclampsia. Obstet Gynecol. 2006; 108: 148-155.
75. Assi F, Fruscio R, Bonardi C, et al. Pentraxin 3 in plasma and vaginal fluid in women with preterm delivery. Bjog. 2007; 114: 143-147.
76. Cruciani L, Romero R, Vaisbuch E, et al. Pentraxin 3 in amniotic fluid: A novel association with intra-amniotic infection and inflammation. J Perinat Med. 2010; 38: 161-171.
77. Doni A, Paffoni A, Nebuloni M, et al. The long pentraxin 3 is a soluble and cell-associated component of the human semen. Int J Androl. 2007; 32: 255-264.
78. Olesen R,Wejse C, Velez DR, et al. DC-SIGN (CD209), pentraxin 3 and vitamin D receptor gene variants associate with pulmonary tuberculosis risk in West Africans. Genes Immun. 2007; 8: 456-467.
79. Chiarini M, Sabelli C, Melotti P, et al. PTX3 genetic variations affect the risk of Pseudomonas aeruginosa airway colonization in cystic fibrosis patients. Genes Immun. 2010;11: 665-670.
80. May L, Kuningas M, van Bodegom D, et al. Genetic variation in pentraxin (PTX) 3 gene associates with PTX3 production and fertility in women. Biol Reprod. 2010; 82: 299-304.
81. Mantovani A, Locati M, Vecchi A, et al. Decoy receptors: A strategy to regulate inflammatory cytokines and chemokines. Trends Immunol. 2001; 22: 328-336.
82. Mantovani A, Bonecchi R, Locati M. Tuning inflammation and immunity by chemokine sequestration: Decoys and more. Nat Rev Immunol. 2006; 6: 907-918.
83. Nibbs RJ,Wylie SM, Yang J, et al. Cloning and characterization of a novel promiscuous human beta-chemokine receptor D6. J Biol Chem. 1997; 272: 32078-32083.
84. Bonecchi R, Locati M, Galliera E, et al. Differential recognition and scavenging of native and truncated macrophagederived chemokine (macrophage-derived chemokine/CC chemokine ligand 22) by the D6 decoy receptor. J Immunol.2004; 172: 4972-4976.
85. Nibbs RJ, Kriehuber E, Ponath PD, et al. The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors. Am J Pathol. 2001; 158: 867-877.
86. Bonecchi R, Borroni EM, Anselmo A, et al. Regulation of D6 chemokine scavenging activity by ligand- and Rab11-dependent surface up-regulation. Blood. 2008; 112: 493-503.
87. Savino B, Borroni EM, Torres NM, et al. Recognition versus adaptive up-regulation and degradation of CC chemokines by the chemokine decoy receptor D6 are determined by their N-terminal sequence. J Biol Chem. 2009; 284: 26207-26215.
88. Martinez de la Torre Y, Locati M, Buracchi C, et al. Increased inflammation in mice deficient for the chemokine decoy receptor D6. Eur J Immunol. 2005; 35: 1342-1346.
89. Jamieson T, Cook DN, Nibbs RJ, et al. The chemokine receptor D6 limits the inflammatory response in vivo. Nat Immunol. 2005; 6: 403-411.
90. Vetrano S, Borroni EM, Sarukhan A, et al. The lymphatic system controls intestinal inflammation and inflammationassociated colon cancer through the chemokine decoy receptor D6. Gut. 2010; 59: 197-206.
91. Martinez de la Torre Y, Buracchi C, Borroni EM, et al. Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6. Proc Natl Acad Sci U S A. 2007; 104: 2319-2324.
92. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med. 2002; 346: 752-763.
93. Wessels JM, Linton NF, Croy BA, et al. A review of molecular contrasts between arresting and viable porcine attachment sites. Am J Reprod Immunol. 2007; 58: 470-480.